Cargando…

Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values

BACKGROUND: Knowing the true infected and symptomatic case fatality ratios (IFR and CFR) for COVID-19 is of high importance for epidemiological model projections. Early in the pandemic many locations had limited testing and reporting, so that standard methods for determining IFR and CFR required lar...

Descripción completa

Detalles Bibliográficos
Autores principales: Rothman, Jessica E., Eidelberg, David, Rothman, Samantha L., Holford, Theodore R., Rothman, Douglas L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372929/
https://www.ncbi.nlm.nih.gov/pubmed/34407073
http://dx.doi.org/10.1371/journal.pone.0253843
_version_ 1783739857266278400
author Rothman, Jessica E.
Eidelberg, David
Rothman, Samantha L.
Holford, Theodore R.
Rothman, Douglas L.
author_facet Rothman, Jessica E.
Eidelberg, David
Rothman, Samantha L.
Holford, Theodore R.
Rothman, Douglas L.
author_sort Rothman, Jessica E.
collection PubMed
description BACKGROUND: Knowing the true infected and symptomatic case fatality ratios (IFR and CFR) for COVID-19 is of high importance for epidemiological model projections. Early in the pandemic many locations had limited testing and reporting, so that standard methods for determining IFR and CFR required large adjustments for missed cases. We present an alternate approach, based on results from the countries at the time that had a high test to positive case ratio to estimate symptomatic CFR. METHODS: We calculated age specific (0–69, 70–79, 80+ years old) time corrected crude symptomatic CFR values from 7 countries using two independent time to fatality correction methods. Data was obtained through May 7, 2020. We applied linear regression to determine whether the mean of these coefficients had converged to the true symptomatic CFR values. We then tested these coefficients against values derived in later studies as well as a large random serological study in NYC at that time. RESULTS: The age dependent symptomatic CFR values accurately predicted the percentage of the population infected as reported by two random testing studies in NYC. They also were in good agreement with later studies that estimated age specific IFR and CFR values from serological studies and more extensive data sets available later in the pandemic. CONCLUSIONS: We found that for regions with extensive testing it is possible to get early accurate symptomatic CFR coefficients. These values, in combination with an estimate of the age dependence of infection, allows symptomatic CFR values and percentage of the population that is infected to be determined in similar regions with limited testing.
format Online
Article
Text
id pubmed-8372929
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-83729292021-08-19 Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values Rothman, Jessica E. Eidelberg, David Rothman, Samantha L. Holford, Theodore R. Rothman, Douglas L. PLoS One Research Article BACKGROUND: Knowing the true infected and symptomatic case fatality ratios (IFR and CFR) for COVID-19 is of high importance for epidemiological model projections. Early in the pandemic many locations had limited testing and reporting, so that standard methods for determining IFR and CFR required large adjustments for missed cases. We present an alternate approach, based on results from the countries at the time that had a high test to positive case ratio to estimate symptomatic CFR. METHODS: We calculated age specific (0–69, 70–79, 80+ years old) time corrected crude symptomatic CFR values from 7 countries using two independent time to fatality correction methods. Data was obtained through May 7, 2020. We applied linear regression to determine whether the mean of these coefficients had converged to the true symptomatic CFR values. We then tested these coefficients against values derived in later studies as well as a large random serological study in NYC at that time. RESULTS: The age dependent symptomatic CFR values accurately predicted the percentage of the population infected as reported by two random testing studies in NYC. They also were in good agreement with later studies that estimated age specific IFR and CFR values from serological studies and more extensive data sets available later in the pandemic. CONCLUSIONS: We found that for regions with extensive testing it is possible to get early accurate symptomatic CFR coefficients. These values, in combination with an estimate of the age dependence of infection, allows symptomatic CFR values and percentage of the population that is infected to be determined in similar regions with limited testing. Public Library of Science 2021-08-18 /pmc/articles/PMC8372929/ /pubmed/34407073 http://dx.doi.org/10.1371/journal.pone.0253843 Text en © 2021 Rothman et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Rothman, Jessica E.
Eidelberg, David
Rothman, Samantha L.
Holford, Theodore R.
Rothman, Douglas L.
Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values
title Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values
title_full Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values
title_fullStr Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values
title_full_unstemmed Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values
title_short Analysis of the time course of COVID-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic CFR values
title_sort analysis of the time course of covid-19 cases and deaths from countries with extensive testing allows accurate early estimates of the age specific symptomatic cfr values
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8372929/
https://www.ncbi.nlm.nih.gov/pubmed/34407073
http://dx.doi.org/10.1371/journal.pone.0253843
work_keys_str_mv AT rothmanjessicae analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues
AT eidelbergdavid analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues
AT rothmansamanthal analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues
AT holfordtheodorer analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues
AT rothmandouglasl analysisofthetimecourseofcovid19casesanddeathsfromcountrieswithextensivetestingallowsaccurateearlyestimatesoftheagespecificsymptomaticcfrvalues